Drug Type ASO |
Synonyms- |
Action modulators |
Mechanism Akt modulators(Proto-oncogene proteins c-akt modulators), BAX modulators(Apoptosis regulator BAX modulators), Bcl-2 modulators(Apoptosis regulator Bcl-2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Neurodegenerative Diseases | Preclinical | China | 07 Jan 2026 |





